Clinical Trials
74 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
LUCIDA_2
FutureChem
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Promontory Therapeutics Inc.
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
Eutilex
PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
URODETECT-WP1
Novosanis NV
MDPK67b in Patients With Prostate Cancer
Med Discovery SA
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.
Orca Therapeutics B.V.
Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel⢠Platform
miR Scientific LLC
Evaluation of the Sentinel⢠PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico
miR Scientific LLC
Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer
HTA Co., Ltd.
Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
Primo Biotechnology Co., Ltd
Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer
Qilu Pharmaceutical Co., Ltd.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
Namida Lab
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With ZoladexĀ® 10.8mg
Luye Pharma Group Ltd.
CADENCE
MiRXES Pte Ltd
WEE1
Impact Therapeutics, Inc.
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
Angiodynamics, Inc.
MyProstateScore Equivalency With and Without DRE
LynxDx
RESTORE
Blue Note Therapeutics
ExoDx Prostate Evaluation in Active Surveillance Patient Population
Exosome Diagnostics, Inc.
Decision Impact Trial of the ExoDx Prostate (IntelliScore)
Exosome Diagnostics, Inc.
A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening
TSH Biopharm Corporation Limited
Assessment of VMCore Biopsy Versus Standard of Care Biopsy
Uro-1 Medical
To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers
Peptron, Inc.
A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
PIONEER
SpeciCare
LPM-012
Lightpoint Medical Limited
A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
Jiangsu HengRui Medicine Co., Ltd.
Study to Evaluate the Safety of Nanoxel M Inj.
Samyang Biopharmaceuticals Corporation
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γΓ T Cells for Relapsed or Refractory Solid Tumour
CytoMed Therapeutics Pte Ltd
Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the SonablateĀ® 500 System in Canada
SonaCare Medical
SetPace
SonaCare Medical
STAR
SonaCare Medical
ClariCore⢠Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy
Precision Biopsy, Inc.
ClariCore Optical Biopsy System Used in TRUS (Trans-Rectal Ultrasound)-Guided Prostrate Biopsy
Precision Biopsy, Inc.
SCORE
Precision Biopsy, Inc.
PERSEE II
Mauna Kea Technologies
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
Placon Therapeutics
Comparison of a Novel Leuprolide With Market Leuprolide
Lee's Pharmaceutical Limited
PRIORITY
MDx Health
FOC/DYN
EDAP TMS S.A.
ProRAFT
Trod Medical N.V.
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
CellMaxLife
Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Threshold Pharmaceuticals
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer
Panacela Labs LLC
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
Optimata Ltd.